Page last updated: 2024-11-06

lysergic acid diethylamide and ANS (Autonomic Nervous System) Diseases

lysergic acid diethylamide has been researched along with ANS (Autonomic Nervous System) Diseases in 1 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borsutzky, M1
Passie, T1
Paetzold, W1
Emrich, HM1
Schneider, U1

Other Studies

1 other study available for lysergic acid diethylamide and ANS (Autonomic Nervous System) Diseases

ArticleYear
[Hawaiian baby woodrose: (Psycho-) Pharmacological effects of the seeds of Argyreia nervosa. A case-orientated demonstration].
    Der Nervenarzt, 2002, Volume: 73, Issue:9

    Topics: Arousal; Autonomic Nervous System Diseases; Consciousness Disorders; Dose-Response Relationship, Dru

2002